[SRNE] QoQ Quarter Result on 30-Sep-2013 [#Q3]

Stock
[SRNE] Sorrento Therapeutics, Inc.
Announcement Date
14-Nov-2013
Financial Year
2013
Quarter
30-Sep-2013 [#Q3]
Profit Trend
QoQ- 29.15%
YoY- -170.43%
Quarter Report
SRNE's Result
SRNE's Financial Summary
View:
Show?
Quarter Result
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
Revenue 775 976 101 84 142 134 122 244.16%
PBT -8,454 -10,093 -11,296 -3,356 -4,737 -2,522 -3,236 90.02%
Tax 5 4 4 2 2 2 -3,090 -
NP -8,454 -10,093 -11,296 -3,356 -4,737 -2,522 -1,755 186.04%
Tax Rate - - - - - - - -
Total Cost 9,229 11,069 11,397 3,440 4,878 2,656 1,877 189.99%
Ratio Analysis
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
NP Margin -1,090.84 -1,034.12 -11,217.68 -4,005.73 -3,345.11 -1,881.46 -1,438.58 -16.88%
Per Share
30/06/14 31/03/14 31/12/13 30/09/13 30/06/13 31/03/13 31/12/12 CAGR
EPS -0.33 -0.44 -0.49 -0.24 -0.35 -0.20 -0.14 77.39%
EPS Diluted -0.33 -0.44 -0.49 -0.24 -0.35 -0.20 -0.14 77.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.